Insider · CIK 0002063933
Timothy C Fiori
Files at ICCC (IMMUCELL CORP /DE/). First filing -, latest -.
In brief
Timothy C Fiori files SEC Form 4 as CFO and director at ICCC (IMMUCELL CORP /DE/). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Timothy C Fiori has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | ICCC IMMUCELL CORP /DE/ | AGrant or award Stock Options (right to buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Jan 29, 2026 |
| Apr 16, 2025 | ICCC IMMUCELL CORP /DE/ | AGrant or award Incentive Stock Options (Right to buy)derivative | +30,000 | $5.49 | $165k | 30,000 | Apr 23, 2025 |
Questions about Timothy C Fiori
Answered from the filings on this page, as of the latest one.
Is Timothy C Fiori buying or selling?
Timothy C Fiori has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Timothy C Fiori's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Timothy C Fiori has 0.
Where does Timothy C Fiori file Form 4?
Timothy C Fiori has filed Form 4 at ICCC (IMMUCELL CORP /DE/) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.